All articles by Ross Law

Ross Law

Ross Henry Law is a reporter for Medical Device Network. His key interest areas in healthcare include regulation, mental health, neurology, oncology, and Alzheimer's disease. Ross also has extensive prior experience in covering the captive insurance, retail, and technology sectors.

FDA clears CMR Surgical’s Versius Plus robot

CMR Surgical has secured US Food and Drug Administration (FDA) clearance for its Versius Plus minimally invasive robotic surgical system,…
Sanome to roll out AI infection detection tool in two UK hospitals

The UK’s Royal Hospital for Neuro-disability and the East Kent Hospitals University NHS Foundation Trust have tapped Sanome’s MEMORI platform…
May Health gains CE mark for infertility treatment

France-headquartered May Health has secured a European CE mark for its Anavi system to address infertility in women with polycystic…
FDA removes patient-identifiable RWE requirement for device submissions

The US Food and Drug Administration (FDA) is removing a limitation on the use of real-world evidence (RWE), clearing the…
Olympus launches second VC fund with $150m commitment

Olympus Corporation has committed $150m to a new venture capital (VC) fund, aiming to deploy the capital to promising medtech…

Philips doubles down on image-guided therapy with SpectraWAVE acquisition

Philips has signed a deal to acquire enhanced vascular imaging (EVI) product developer SpectraWAVE, expanding the Dutch medtech giant’s minimally…
FDA clears Bendit’s steerable vascular microcatheter

Israel-based Bendit Technologies’ steerable microcatheter has gained clearance from the US Food and Drug Administration (FDA), providing US clinicians with…
Subsense secures $10m to advance BCI R&D efforts

US-based Subsense has raised $10m, bringing the brain-computer interface (BCI) developer’s total funding to $27m since it emerged from stealth…
FDA clears Flow Neuroscience’s at-home depression treatment in US first

The US Food and Drug Administration (FDA) has cleared Flow Neuroscience’s at-home, non-drug depression treatment, making it the first device…
FDA greenlights Lumos Labs’ digital ADHD therapeutic

Lumos Labs has gained US Food and Drug Administration (FDA) clearance for LumosityRx, a prescription digital therapeutic (PDT) that aims…